Clinical trial ID (Registry) Intervention Size Randomised Blinded Status Country of origin (pharma sponsor)
NCT04302766 (ClinicalTrials.gov) Arm A: remdesivir Unspecified Unspecified Unspecified Available USA
NCT04292899 (ClinicalTrials.gov) Arm A: remdesivir Arm B: standard treatment 400 Yes No Recruiting USA and Asia
NCT04292730 (ClinicalTrials.gov) Arm A: remdesivir Arm B: standard treatment 600 Yes No Recruiting USA and Asia
NCT04280705 (ClinicalTrials.gov) Arm A: remdesivir Arm B: placebo 394 Yes Double Recruiting USA and South Korea
2020-000841-15 (EU-CTR) Arm A: remdesivir Arm B: standard treatment 400 Yes No Recruiting Worldwide
2020-000842-32 (EU-CTR) ) Arm A: remdesivir Arm B: standard treatment 600 Yes No Recruiting Worldwide
NCT04252664 (ClinicalTrials.gov) Arm A: remdesivir Arm B: placebo 308 Yes Quadruple Recruiting China
NCT04257656 (ClinicalTrials.gov) Arm A: remdesivir Arm B: placebo 453 Yes Quadruple Recruiting China
NCT04315948 (ClinicalTrials.gov) Arm A: remdesivir Arm B: lopinavir/ritonavir Arm C: lopinavir/ritonavir and interferon beta 1a Arm D: hydroxychloroquine Arm E: standard treatment 3100 Yes No Recruiting France